Clinical & Experimental Metastasis

Papers
(The TQCC of Clinical & Experimental Metastasis is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Congratulations to Prof. em. Garth L. Nicolson – co-founder of Clinical & Experimental Metastasis86
PET/CT in assessment of colorectal liver metastases: a comprehensive review with emphasis on 18F-FDG67
LITAF inhibits colorectal cancer stemness and metastatic behavior by regulating FOXO1-mediated SIRT1 expression64
The movement of mitochondria in breast cancer: internal motility and intercellular transfer of mitochondria48
Prediction of transformation in the histopathological growth pattern of colorectal liver metastases after chemotherapy using CT-based radiomics43
Personalized therapy in oncology: melanoma as a paradigm for molecular-targeted treatment approaches43
Detection of melanoma, breast cancer and head and neck squamous cell cancer sentinel lymph nodes by Tc-99m Tilmanocept (Lymphoseek®)35
Metastatic profiling of HER2-positive breast cancer cell lines in xenograft models35
EGFL6 promotes bone metastasis of lung adenocarcinoma by increasing cancer cell malignancy and bone resorption33
The effect of the low stromal ratio induced by neoadjuvant chemotherapy on recurrence patterns in borderline resectable pancreatic ductal adenocarcinoma33
Multiple myeloma: clinical characteristics, current therapies and emerging innovative treatments targeting ribosome biogenesis dynamics32
Cancer neoantigens as potential targets for immunotherapy32
Stereotactic body radiotherapy to lymph nodes in oligoprogressive castration-resistant prostate cancer patients: a post hoc analysis from two phase I clinical trials31
Molecular prognostic indicators in HPV-positive oropharyngeal cancer: an updated review26
Letter: Estimating the baseline local recurrence rate for a brain metastasis after neurosurgical resection25
Preoperative embolization of renal cell carcinoma metastases to the bone prior to stabilization procedures does not result in reduction in intraoperative blood loss19
Cell blebbing novel therapeutic possibilities to counter metastasis19
Oncolytic intralesional therapy for metastatic melanoma19
Axillary nodal staging in breast cancer: what have we learned?18
Data mining of key genes expression in hepatocellular carcinoma: novel potential biomarkers of diagnosis prognosis or progression18
Cardiooncology—dealing with modern drug treatment, long-term complications, and cancer survivorship17
High sensitivity flow cytometry immunophenotyping increases the diagnostic yield of malignant pleural effusions17
Risk factors for surgical site infection and association of surgical site infection with survival of lower rectal cancer patients without clinical lateral pelvic lymph node metastasis (clinical Stage 16
Topography and probability diagram of cervical and intra-parotid lymph node metastasis in parotid gland cancer15
Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer15
Therapy resistance and metastasis15
Correction: CXCL2-CXCR2 axis mediates αV integrin-dependent peritoneal metastasis of colon cancer cells15
Mechanisms of breast cancer metastasis15
Editorial: Cancer metastasis through the lymphovascular system: molecular mechanisms of cancer metastasis15
CT-based deep learning model: a novel approach to the preoperative staging in patients with peritoneal metastasis14
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations14
Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer14
Effect of liver metastasis on the efficacy of immune checkpoint inhibitors in cancer patients: a systemic review and meta-analysis13
Current preclinical models of brain metastasis13
Nectin-4 is frequently expressed in primary salivary gland cancer and corresponding lymph node metastases and represents an important treatment-related biomarker13
The influence of an enamine usnic acid derivative (a tyrosyl-DNA phosphodiesterase 1 inhibitor) on the therapeutic effect of topotecan against transplanted tumors in vivo13
Antigen presenting cells in cancer immunity and mediation of immune checkpoint blockade13
Defining the landscape of metabolic dysregulations in cancer metastasis12
Oligoprogressive castration-resistant prostate cancer treated with metastases-directed stereotactic body radiation therapy: predictive factors for patients’ selection12
Fluid shear stress influences invasiveness of HeLa cells through the induction of autophagy12
Correction: SETBP1 activation upon MDM4-enhanced ubiquitination of NR3C1 triggers dissemination of colorectal cancer cells11
Etiology and treatment of cancer-related secondary lymphedema11
Histopathological growth patterns of neuroendocrine tumor liver metastases11
Efficacy and safety of PARPis combined with an ICIs for advanced or metastatic triple-negative breast cancer: a single-arm meta-analysis11
Tumor microenvironment dynamics in oral cancer: unveiling the role of inflammatory cytokines in a syngeneic mouse model11
Should EUS-FNA be considered also for the diagnosis of peripheral small pulmonary lesions?10
Donald L. Morton Memorial Lecture: the legacy of Donald Morton: past, present and future10
Stereotactic radiotherapy for liver oligometastases: a pooled analysis following the estro/eortc consensus recommendations10
Nanoparticles loaded with circ_0086375 for suppressing the tumorigenesis of pancreatic cancer by targeting the miR-646/SLC4A4 axis10
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results10
Breast cancer disparities in outcomes; unmasking biological determinants associated with racial and genetic diversity10
The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic study10
Long non-coding RNA NRSN2-AS1, transcribed by SOX2, promotes progression of esophageal squamous cell carcinoma by regulating the ubiquitin-degradation of PGK19
Histopathological growth patterns of resected non-colorectal, non-neuroendocrine liver metastases: a retrospective multicenter study9
Computational markers for personalized prediction of outcomes in non-small cell lung cancer patients with brain metastases9
Beta-blocker adjunct therapy as a prospective anti-metastatic with cardio-oncologic regulation9
Targeting PADI2 as a potential therapeutic strategy against metastasis in oral cancer via suppressing EMT-mediated migration and invasion and CCL3/5-induced angiogenesis9
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy 9
Dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single-cell and spatial transcriptomics9
‘Sandwich treatment’ for posterior fossa brain metastases with volume larger than 4cm3: a multicentric retrospective study9
Differentiation of benign and metastatic lymph nodes in soft tissue sarcoma9
0.034976005554199